CIK: 0001535610
申告総資産額
$4507.3万
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Bluebird Bio INC | 株式-その他 | 10.23% | — | +8.12% | |
| 2 | ✓ | Ishares Tr | 株式-その他 | 8.66% | -19.97% | EXIT | |
| 3 | BMY | Bristol-myers Squibb Co | 株式-ヘルスケア | 7.72% | — | -5.20% | |
| 4 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-大型株・グロース | 7.24% | — | — | |
| 5 | AZN | AstraZeneca PLC | 株式-ヘルスケア | 7.01% | — | +232.95% | |
| 6 | SRPT | Sarepta Therapeutics, Inc. | 株式-ヘルスケア | 6.79% | — | +24.23% | |
| 7 | AZN | AstraZeneca PLC | 株式-ヘルスケア | 3.52% | — | +267.65% | |
| 8 | ✓ | Odonate Therapeu | 株式-その他 | 2.79% | — | — | |
| 9 | ✓ | Alnylam Pharmaceuticals INC | 株式-その他 | 2.75% | — | -49.35% | |
| 10 | ✓ | Amicus Therapeutics INC | 株式-その他 | 2.02% | — | +150.63% | |
| 11 | MRK | Merck & Co., Inc. | 株式-ヘルスケア | 2.02% | — | -36.54% | |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 株式-ヘルスケア | 1.86% | — | -67.92% | |
| 13 | ✓ | Juno Therapeutics INC | 株式-その他 | 1.86% | — | — | |
| 14 | CI | The Cigna Group | 株式-ヘルスケア | 1.84% | — | — | |
| 15 | ✓ | Zogenix INC | 株式-その他 | 1.67% | — | -36.49% | |
| 16 | ✓ | Alnylam Pharmaceuticals INC | 株式-その他 | 1.62% | — | -79.89% | |
| 17 | ✓ | Esperion Therapeutics INC Ne | 株式-その他 | 1.49% | — | +12.91% | |
| 18 | ✓ | Halozyme Therapeutics INC | 株式-その他 | 1.36% | — | -62.03% | |
| 19 | ✓ | Sangamo Therapeutics INC | 株式-その他 | 1.34% | — | +51.61% | |
| 20 | ESPR | Esperion Therapeutics INC | 株式-その他 | 1.27% | — | +70.57% | |
| 21 | ✓ | Alkermes PLC | 株式-その他 | 1.18% | — | — | |
| 22 | ✓ | Bluebird Bio INC | 株式-その他 | 1.17% | — | -14.16% | |
| 23 | ✓ | Sarepta Therapeutics INC | 株式-その他 | 1.11% | — | +184.17% | |
| 24 | VRTX | Vertex Pharmaceuticals Incorporated | 株式-ヘルスケア | 0.98% | — | -61.34% | |
| 25 | ✓ | Ionis Pharmaceuticals INC | 株式-その他 | 0.97% | — | +0.42% | |
| 26 | ✓ | Ionis Pharmaceuticals INC | 株式-その他 | 0.84% | — | -23.70% | |
| 27 | ✓ | Sage Therapeutics INC | 株式-その他 | 0.78% | — | -50.14% | |
| 28 | ONCEEUR | Spark Therapeutics INC | 株式-その他 | 0.77% | — | — | |
| 29 | ✓ | Spdr S&p Biotech | 株式-その他 | 0.75% | — | — | |
| 30 | ✓ | Incyte CORP | 株式-その他 | 0.68% | — | +39.27% | |
| 31 | ✓ | Radius Health INC | 株式-その他 | 0.66% | — | — | |
| 32 | ✓ | Gw Pharmaceuticals PLC | 株式-その他 | 0.63% | — | -69.28% | |
| 33 | ✓ | Sangamo Therapeutics INC | 株式-その他 | 0.61% | — | +374.78% | |
| 34 | ✓ | Zogenix INC | 株式-その他 | 0.60% | — | -12.63% | |
| 35 | ✓ | Sage Therapeutics INC | 株式-その他 | 0.58% | — | — | |
| 36 | MNKD | Mannkind CORP | 株式-その他 | 0.45% | — | — | |
| 37 | ✓ | 株式-その他 | 0.45% | — | — | ||
| 38 | ✓ | Alexion Pharmaceuticals INC | 株式-その他 | 0.40% | — | — | |
| 39 | ✓ | Amicus Therapeutics INC | 株式-その他 | 0.39% | — | +300.00% | |
| 40 | ✓ | Oncobiologics INC | 株式-その他 | 0.37% | — | -12.78% | |
| 41 | ABBV | Abbvie INC | 株式-ヘルスケア | 0.36% | — | — | |
| 42 | ✓ | Intercept Pharmaceuticals INC | 株式-その他 | 0.35% | — | +347.00% | |
| 43 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 0.33% | — | — | |
| 44 | ✓ | Amag Pharmaceuticals INC Cmn Stk | 株式-その他 | 0.33% | — | -39.35% | |
| 45 | VTGNUSD | Vistagen Therapeutics INC | 株式-その他 | 0.32% | — | — | |
| 46 | ✓ | Versartis INC | 株式-その他 | 0.30% | — | +40.41% | |
| 47 | ✓ | Dermira INC | 株式-その他 | 0.29% | — | — | |
| 48 | BMY | Bristol-Myers Squibb Company | 株式-ヘルスケア | 0.29% | — | +4.88% | |
| 49 | ✓ | Histogenics CORP | 株式-その他 | 0.26% | — | +98.28% | |
| 50 | ✓ | Mannkind CORP | 株式-その他 | 0.26% | — | +35.07% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | AZN | AstraZeneca PLC | +3.7% | +232.95% | 増加 |
| 2 | ✓ | Bluebird Bio INC | +3.4% | +8.12% | 増加 |
| 3 | SRPT | Sarepta Therapeutics, Inc. | +2.4% | +24.23% | 増加 |
| 4 | AZN | AstraZeneca PLC | +1.9% | +267.65% | 増加 |
| 5 | BMY | Bristol-myers Squibb Co | +1.1% | -5.20% | 減少 |
| 6 | ✓ | Amicus Therapeutics INC | +1% | +150.63% | 増加 |
| 7 | ✓ | Incyte CORP | +0.8% | +463.04% | 増加 |
| 8 | ✓ | Sarepta Therapeutics INC | +0.6% | +184.17% | 増加 |
| 9 | ESPR | Esperion Therapeutics INC | +0.6% | +70.57% | 増加 |
| 10 | ✓ | Esperion Therapeutics INC Ne | +0.5% | +12.91% | 増加 |
| 11 | ✓ | Sangamo Therapeutics INC | +0.5% | +51.61% | 増加 |
| 12 | ✓ | Sangamo Therapeutics INC | +0.4% | +374.78% | 増加 |
| 13 | ✓ | Zogenix INC | 0% | -36.49% | 減少 |
| 14 | ✓ | Amarin Corp PLC | -0.2% | -80.89% | 減少 |
| 15 | ✓ | Axovant Sciences LTD | -0.2% | -82.03% | 減少 |
| 16 | ✓ | Axovant Sciences LTD | -0.3% | -75.93% | 減少 |
| 17 | ✓ | Gw Pharmaceuticals PLC | -0.3% | -69.28% | 減少 |
| 18 | ✓ | Prothena CORP PLC | -0.3% | -75.98% | 減少 |
| 19 | ✓ | Fibrogen INC | -0.4% | -80.13% | 減少 |
| 20 | MRK | Merck & Co., Inc. | -0.4% | -36.54% | 減少 |
| 21 | ✓ | Clovis Oncology INC | -0.6% | -93.97% | 減少 |
| 22 | ✓ | Halozyme Therapeutics INC | -0.6% | -62.03% | 減少 |
| 23 | ✓ | Alnylam Pharmaceuticals INC | -0.6% | -49.35% | 減少 |
| 24 | VRTX | Vertex Pharmaceuticals Incorporated | -0.6% | -61.34% | 減少 |
| 25 | VRTX | Vertex Pharmaceuticals Incorporated | -1.6% | -67.92% | 減少 |
| 26 | ✓ | Alnylam Pharmaceuticals INC | -2.5% | -79.89% | 減少 |
| 27 | ABBV | AbbVie Inc. | -6.2% | -99.77% | 減少 |
| 28 | MRK | Merck & Co., Inc. | -9.1% | -58.72% | 減少 |
| 29 | ✓ | Spdr S&p 500 ETF Tr | — | EXIT | 全売却 |
| 30 | ✓ | Ishares Tr | — | EXIT | 全売却 |
| 31 | ✓ | Ishares Tr | — | NEW | 新規購入 |
| 32 | SPY | State Street SPDR S&P 500 ETF Trust | — | NEW | 新規購入 |
| 33 | ✓ | Dbv Technologies S A | — | EXIT | 全売却 |
| 34 | ✓ | Odonate Therapeu | — | NEW | 新規購入 |
| 35 | ✓ | Juno Therapeutics INC | — | NEW | 新規購入 |
| 36 | ✓ | Kite Pharma INC | — | EXIT | 全売却 |
| 37 | ✓ | Seattle Genetics INC. | — | EXIT | 全売却 |
| 38 | ✓ | Alkermes PLC | — | NEW | 新規購入 |
| 39 | ✓ | Dbv Technologies S A | — | EXIT | 全売却 |
| 40 | ABBV | AbbVie Inc. | — | NEW | 新規購入 |
| 41 | ✓ | United Therapeutics CORP Del | — | EXIT | 全売却 |
| 42 | ✓ | Insmed INC | — | EXIT | 全売却 |
| 43 | ONCEEUR | Spark Therapeutics INC | — | NEW | 新規購入 |
| 44 | ✓ | Spdr S&p Biotech | — | NEW | 新規購入 |
| 45 | ✓ | Cytokinetics INC | — | EXIT | 全売却 |
| 46 | ✓ | Radius Health INC | — | NEW | 新規購入 |
| 47 | ✓ | Insmed INC | — | EXIT | 全売却 |
| 48 | ✓ | Sage Therapeutics INC | — | NEW | 新規購入 |
| 49 | MNKD | Mannkind CORP | — | NEW | 新規購入 |
| 50 | ✓ | — | NEW | 新規購入 |